Oppenheimer Reiterates Outperform Rating on ESSA Pharma (EPIX)
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $17.00 price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


